JP2008509084A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509084A5
JP2008509084A5 JP2007513303A JP2007513303A JP2008509084A5 JP 2008509084 A5 JP2008509084 A5 JP 2008509084A5 JP 2007513303 A JP2007513303 A JP 2007513303A JP 2007513303 A JP2007513303 A JP 2007513303A JP 2008509084 A5 JP2008509084 A5 JP 2008509084A5
Authority
JP
Japan
Prior art keywords
epitope
activated
polypeptide
cells
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007513303A
Other languages
English (en)
Japanese (ja)
Other versions
JP5710854B2 (ja
JP2008509084A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/016441 external-priority patent/WO2005110456A2/en
Publication of JP2008509084A publication Critical patent/JP2008509084A/ja
Publication of JP2008509084A5 publication Critical patent/JP2008509084A5/ja
Application granted granted Critical
Publication of JP5710854B2 publication Critical patent/JP5710854B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007513303A 2004-05-11 2005-05-11 Ｔ細胞死誘導エピトープ Expired - Fee Related JP5710854B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57016104P 2004-05-11 2004-05-11
US60/570,161 2004-05-11
PCT/US2005/016441 WO2005110456A2 (en) 2004-05-11 2005-05-11 T-cell death-inducing epitopes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012223627A Division JP2013049679A (ja) 2004-05-11 2012-10-05 Ｔ細胞死誘導エピトープ

Publications (3)

Publication Number Publication Date
JP2008509084A JP2008509084A (ja) 2008-03-27
JP2008509084A5 true JP2008509084A5 (https=) 2008-06-26
JP5710854B2 JP5710854B2 (ja) 2015-04-30

Family

ID=35394670

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007513303A Expired - Fee Related JP5710854B2 (ja) 2004-05-11 2005-05-11 Ｔ細胞死誘導エピトープ
JP2012223627A Pending JP2013049679A (ja) 2004-05-11 2012-10-05 Ｔ細胞死誘導エピトープ
JP2015093320A Expired - Fee Related JP6109234B2 (ja) 2004-05-11 2015-04-30 Ｔ細胞死誘導エピトープ

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012223627A Pending JP2013049679A (ja) 2004-05-11 2012-10-05 Ｔ細胞死誘導エピトープ
JP2015093320A Expired - Fee Related JP6109234B2 (ja) 2004-05-11 2015-04-30 Ｔ細胞死誘導エピトープ

Country Status (20)

Country Link
US (3) US20060003940A1 (https=)
EP (2) EP1751300B1 (https=)
JP (3) JP5710854B2 (https=)
KR (3) KR20130018989A (https=)
CN (3) CN105777867A (https=)
AR (1) AR048840A1 (https=)
AU (1) AU2005244081B2 (https=)
BR (1) BRPI0510561A (https=)
CA (1) CA2565872C (https=)
CL (1) CL2008003587A1 (https=)
EC (1) ECSP067055A (https=)
ES (1) ES2655833T3 (https=)
IL (1) IL178837A (https=)
MX (1) MXPA06012987A (https=)
NO (1) NO20065648L (https=)
NZ (3) NZ578356A (https=)
RU (1) RU2412945C2 (https=)
TW (3) TWI454274B (https=)
UA (3) UA105492C2 (https=)
WO (1) WO2005110456A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040116333A1 (en) 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
US7744888B2 (en) 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
UY28886A1 (es) 2004-05-10 2005-12-30 Boehringer Ingelheim Int Anticuerpos que consisten en polipéptidos y derivados conprendiendo tres secuencias conteniendo respectivamente los siguientes números de seq. id: 1-3 y 4-6; 7-9 y 10-12 y 13-15 ó 16-18
ES2655833T3 (es) 2004-05-11 2018-02-21 AbGenomics Coöperatief U.A. Epítopos que inducen la muerte de células T
WO2009093251A2 (en) * 2008-01-24 2009-07-30 Gavish-Galilee Bio Applications Ltd Reovirus vaccine based on sigma c protein sequence
EP2718325A4 (en) 2011-06-13 2015-03-11 ABGENOMICS COöPERATIEF U A ANTI-PSGL-1 ANTIBODIES AND USES THEREOF
IL260289B (en) 2016-01-08 2022-08-01 Bioalliance Cv Tetravalent anti-psgl-1 antibodies and uses thereof
KR20250159733A (ko) 2017-01-11 2025-11-11 브리스톨-마이어스 스큅 컴퍼니 Psgl-1 길항제 및 그의 용도
PE20250933A1 (es) 2017-03-14 2025-04-02 Five Prime Therapeutics Inc Anticuerpos de union a vista a ph acido
BR112020019083A2 (pt) 2018-03-21 2020-12-29 Five Prime Therapeutics, Inc. Anticorpos, ácido nucleico, composições, célula e métodos para preparar um anticorpo, para tratar câncer, para tratar uma doença infecciosa, para tratar uma inflamação, para a identificação de um anticorpo, para melhorar a eficácia antitumoral de um anticorpo, para melhorar a farmacocinética de um anticorpo, para selecionar um anticorpo, para melhorar a eficácia de anticorpos, para isolar anticorpos, para detectar vista em uma amostra e para tratar câncer
PE20210687A1 (es) 2018-07-11 2021-04-08 Bristol Myers Squibb Co Anticuerpos de union a vista a ph acido

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
JPS61134325A (ja) * 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US5866363A (en) * 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4704692A (en) 1986-09-02 1987-11-03 Ladner Robert C Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5378464A (en) * 1989-03-08 1995-01-03 Board Of Regents Of The University Of Oklahoma Modulation of inflammatory responses by administration of GMP-140 or antibody to GMP-140
US5464778A (en) * 1989-03-08 1995-11-07 Board Of Regents Of The University Of Oklahoma Glycoprotein ligand for P-selectin and methods of use thereof
US5690933A (en) * 1989-05-31 1997-11-25 Glaxo Wellcome Inc. Monoclonal antibodies for inducing tolerance
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US5709859A (en) * 1991-01-24 1998-01-20 Bristol-Myers Squibb Company Mixed specificity fusion proteins
US6309639B1 (en) * 1991-02-05 2001-10-30 The Board Of Regents Of The University Of Oklahoma Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
US6124267A (en) * 1991-02-05 2000-09-26 Southpac Trust Internationals, Inc. O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
US5972625A (en) * 1991-05-06 1999-10-26 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
US5843707A (en) * 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
WO1994014836A1 (en) * 1992-12-18 1994-07-07 Centocor, Inc. Peptide inhibitors of selectin binding
DE69415154T2 (de) * 1993-01-25 1999-07-29 Dana-Farber Cancer Institute, Inc., Boston, Mass. Chimäre selektine erhältlich durch domänenaustauch und ihre verwendungen
WO1995014787A1 (en) * 1993-11-22 1995-06-01 Centocor, Inc. Peptide inhibitors of selecting binding
US6719972B1 (en) * 1994-06-03 2004-04-13 Repligen Corporation Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodies
KR100523506B1 (en) 1995-08-03 2005-10-24 Peptide and O-glycan inhibitors of selectin mediated inflammation
DE19629938C1 (de) * 1996-07-24 1997-11-27 Gsf Forschungszentrum Umwelt E-Cadherin-Mutationen als Grundlage zur Diagnostik und Therapie humaner maligner Tumoren
JP4150082B2 (ja) * 1996-08-27 2008-09-17 カイロン コーポレイション 独特の髄膜炎菌性ｂエピトープを規定するモノクローナル抗体およびワクチン組成物の調製におけるそれらの使用
US5955259A (en) * 1996-12-19 1999-09-21 Brandeis University Method for assessing modulation of potassium ion channel activity
CA2280930C (en) * 1997-02-12 2010-04-06 The Regents Of The University Of Michigan Protein markers for lung cancer and use thereof
US6551994B1 (en) * 1997-04-10 2003-04-22 Mcgill University Compounds and methods for inhibiting the interaction between α-catenin and β-catenin
DE69841894D1 (de) * 1997-11-21 2010-10-21 Merck Serono Biodevelopment Sa Äusseres Membranpolypeptid von Chlamydia pneumoniae sowie Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion
WO1999043353A2 (en) * 1998-02-26 1999-09-02 Boehringer Ingelheim Pharmaceuticals, Inc. Combination anti-selectin and immunosuppressant therapy
CA2347119A1 (en) 1998-10-30 2000-05-11 Genetics Institute, Inc. Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists
DE19925199A1 (de) * 1999-06-01 2000-12-07 Medigene Ag Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
AU2001251612A1 (en) * 2000-04-14 2001-10-30 Millennium Pharmaceuticals, Inc. Roles of jak/stat family members in tolerance induction
EP1325123A4 (en) * 2000-09-12 2004-07-21 Inst Genetics Llc STENOSE- OR RESEARCH INHIBITION BY P-SELECTIN ANTAGONISTS
EP1406930A4 (en) * 2000-12-29 2007-01-10 Savient Pharmaceuticals Inc "ISOLATED MOLECULES WITH SULFATED GROUPING CONTAINING EPITOPES, ANTIBODIES AGAINST SUCH EPITOPES AND USES THEREOF"
US20040002450A1 (en) * 2000-12-29 2004-01-01 Janette Lazarovits Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US20040001839A1 (en) * 2000-12-29 2004-01-01 Avigdor Levanon Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
NZ512341A (en) * 2001-06-13 2004-02-27 Bayer Ag Polynucleotides between 15 and 100 base pairs in length coding for parapoxvirus ovis (PPVO)/vaccinia virus recombinant (VVOV) viral genome fragments
US20040116333A1 (en) * 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
US7744888B2 (en) * 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
AU2002337913A1 (en) * 2001-10-19 2003-04-28 Richard D. Cummings Glycosulfopeptide inhibitors and methods of use thereof
WO2004003166A2 (en) * 2002-07-01 2004-01-08 Savient Pharmaceuticals, Inc. Antibodies and uses thereof
WO2004049907A2 (en) * 2002-11-27 2004-06-17 University Of Louisville Research Foundation Compositions and methods for treating transplants
US20050152906A1 (en) * 2003-06-30 2005-07-14 Avigdor Levanon Specific human antibodies
BRPI0414402A (pt) * 2003-09-15 2006-11-14 Abgenomics Corp moduladores de ligante 1 de glicoproteìna p-selectina
UY28886A1 (es) * 2004-05-10 2005-12-30 Boehringer Ingelheim Int Anticuerpos que consisten en polipéptidos y derivados conprendiendo tres secuencias conteniendo respectivamente los siguientes números de seq. id: 1-3 y 4-6; 7-9 y 10-12 y 13-15 ó 16-18
ES2655833T3 (es) * 2004-05-11 2018-02-21 AbGenomics Coöperatief U.A. Epítopos que inducen la muerte de células T
EP2718325A4 (en) 2011-06-13 2015-03-11 ABGENOMICS COöPERATIEF U A ANTI-PSGL-1 ANTIBODIES AND USES THEREOF

Similar Documents

Publication Publication Date Title
JP2008509084A5 (https=)
Asero et al. Lipid transfer protein: a pan-allergen in plant-derived foods that is highly resistant to pepsin digestion
JP2013512889A5 (https=)
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
JP2005512507A5 (https=)
Kelly et al. T-cell, adhesion, and B-cell epitopes of the cell surface Streptococcus mutans protein antigen I/II
JP2020517628A5 (https=)
CA2253374C (en) Novel osp-c derived peptide fragments
TR200202254T2 (tr) IL-18 Kaynaklı rahatsızlıkların tedavisinde faydalı rekombinant IL-18 antagonistleri.
WO2005000244A3 (en) Methods and compositions for treating rheumatoid arthritis
FI941757A0 (fi) Dermatofagoideista (talopölypunkki) peräisin olevien pääallergeenien T-soluepitoopit
WO2005018424A3 (en) Antibodies specific for fibrillar amyloid and a procedure to detect fibrillar amyloid deposits
JP2013506425A5 (https=)
ES2342971T3 (es) Antigenos recombinantes quimericos de toxoplasma gondii.
Peng et al. Mosquito salivary allergen Aed a 3: cloning, comprehensive molecular analysis, and clinical evaluation
NZ547629A (en) Antibodies binding to conformationally discriminating epitopes of human IGG Fc receptor IIb and IIb
RU2006143689A (ru) Эпитопы, индуцирующие гибель т-клеток
JP2015513314A5 (https=)
JP2005515981A5 (https=)
Welburn VSG structure: similar N-terminal domains can form functional VSGs with different types of C-terminal domain
WO2004041296A3 (en) Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides
JP2008516985A5 (https=)
DE69333709D1 (de) T-zell epitope des raygraspollen-allergens
JP2004505113A5 (https=)
JP2004502782A5 (https=)